UNTREATED METASTATIC SQUAMOUS NECK CANCER WITH OCCULT PRIMARY

Clinical trials for UNTREATED METASTATIC SQUAMOUS NECK CANCER WITH OCCULT PRIMARY explained in plain language.

Never miss a new study

Get alerted when new UNTREATED METASTATIC SQUAMOUS NECK CANCER WITH OCCULT PRIMARY trials appear

Sign up with your email to follow new studies for UNTREATED METASTATIC SQUAMOUS NECK CANCER WITH OCCULT PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists test drug duo in battle against tough head and neck cancers

Disease control Completed

This study tested whether combining two cancer drugs, cetuximab and sorafenib, works better than using cetuximab alone for people with advanced head and neck cancer that has returned or spread. Fifty-five participants were randomly assigned to receive either the combination or th…

Matched conditions: UNTREATED METASTATIC SQUAMOUS NECK CANCER WITH OCCULT PRIMARY

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

UNTREATED METASTATIC SQUAMOUS NECK CANCER WITH OCCULT PRIMARY

Get alerted when new UNTREATED METASTATIC SQUAMOUS NECK CANCER WITH OCCULT PRIMARY trials appear

Scientists test drug duo in battle against tough head and neck cancers